Past, Present and Future: 30 Years of HIV Research

Overview

Journal Nat Rev Microbiol

Specialties Infectious Diseases
Microbiology

Date 2013 Oct 29

PMID 24162027

Citations 106

Authors

Francoise Barre-Sinoussi

Anna Laura Ross

Jean-Francois Delfraissy

Affiliations

Soon will be listed here.

Abstract

This year marks the thirtieth anniversary of the publication of the study that first reported the isolation of HIV-1. In this Timeline article, we provide a historical perspective of some of the major milestones in HIV science, highlighting how translational research has affected treatment and prevention of HIV. Finally, we discuss some of the current research directions and the scientific challenges ahead, in particular in the search for a cure for HIV.

Citing Articles

Anti-HIV-1 Effect of the Fluoroquinolone Enoxacin and Modulation of Pro-Viral hsa-miR-132 Processing in CEM-SS Cells.

Schlosser V, Lightfoot H, Leemann C, Bejoy A, Tiwari S, Schlosshauer J Noncoding RNA. 2025; 11(1.

PMID: 39846686 PMC: 11755467. DOI: 10.3390/ncrna11010008.

Frequent Cocaine Use is Associated With Larger HIV Latent Reservoir Size.

Aouizerat B, Garcia J, Domingues C, Xu K, Quach B, Page G J Acquir Immune Defic Syndr. 2024; 97(2):156-164.

PMID: 39250649 PMC: 11752676. DOI: 10.1097/QAI.0000000000003472.

In Vitro Anti-HIV-1 Activity of Fucoidans from Brown Algae.

Nosik M, Krylova N, Usoltseva R, Surits V, Kireev D, Shchelkanov M Mar Drugs. 2024; 22(8).

PMID: 39195471 PMC: 11355542. DOI: 10.3390/md22080355.

CRISPR-Cpf1 system and its applications in animal genome editing.

Han Y, Jia Z, Xu K, Li Y, Lu S, Guan L Mol Genet Genomics. 2024; 299(1):75.

PMID: 39085660 DOI: 10.1007/s00438-024-02166-x.

Connection Between HIV and Mitochondria in Cardiovascular Disease and Implications for Treatments.

Hinton Jr A, Njai A, Vue Z, Wanjalla C Circ Res. 2024; 134(11):1581-1606.

PMID: 38781302 PMC: 11122810. DOI: 10.1161/CIRCRESAHA.124.324296.

References

Weiss R . Thirty years on: HIV receptor gymnastics and the prevention of infection. BMC Biol. 2013; 11:57. PMC: 3660199. DOI: 10.1186/1741-7007-11-57. View

Buchbinder S, Mehrotra D, Duerr A, Fitzgerald D, Mogg R, Li D . Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet. 2008; 372(9653):1881-1893. PMC: 2721012. DOI: 10.1016/S0140-6736(08)61591-3. View

Walker L, Huber M, Doores K, Falkowska E, Pejchal R, Julien J . Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature. 2011; 477(7365):466-70. PMC: 3393110. DOI: 10.1038/nature10373. View

Maddon P, Dalgleish A, McDougal J, Clapham P, Weiss R, Axel R . The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 1986; 47(3):333-48. DOI: 10.1016/0092-8674(86)90590-8. View

Brenchley J, Price D, Schacker T, Asher T, Silvestri G, Rao S . Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006; 12(12):1365-71. DOI: 10.1038/nm1511. View

Connor E, Sperling R, Gelber R, Kiselev P, Scott G, OSullivan M . Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994; 331(18):1173-80. DOI: 10.1056/NEJM199411033311801. View

Van Damme N, Goff D, Katsura C, Jorgenson R, Mitchell R, Johnson M . The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe. 2008; 3(4):245-52. PMC: 2474773. DOI: 10.1016/j.chom.2008.03.001. View

Hahn B, Shaw G, Arya S, Popovic M, Gallo R, Wong-Staal F . Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature. 1984; 312(5990):166-9. DOI: 10.1038/312166a0. View

Martin M, Gao X, Lee J, Nelson G, Detels R, Goedert J . Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet. 2002; 31(4):429-34. DOI: 10.1038/ng934. View

10.

Sheehy A, Gaddis N, Choi J, Malim M . Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 2002; 418(6898):646-50. DOI: 10.1038/nature00939. View

11.

Hammer S, Squires K, Hughes M, Grimes J, Demeter L, Currier J . A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med. 1997; 337(11):725-33. DOI: 10.1056/NEJM199709113371101. View

12.

Pantaleo G, Graziosi C, Demarest J, Butini L, Montroni M, Fox C . HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature. 1993; 362(6418):355-8. DOI: 10.1038/362355a0. View

13.

Popovic M, Sarngadharan M, Read E, Gallo R . Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science. 1984; 224(4648):497-500. DOI: 10.1126/science.6200935. View

14.

Wong J, Hezareh M, Gunthard H, Havlir D, Ignacio C, Spina C . Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 1997; 278(5341):1291-5. DOI: 10.1126/science.278.5341.1291. View

15.

Chun T, Stuyver L, Mizell S, Ehler L, Mican J, Baseler M . Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A. 1997; 94(24):13193-7. PMC: 24285. DOI: 10.1073/pnas.94.24.13193. View

16.

Hutter G, Nowak D, Mossner M, Ganepola S, Mussig A, Allers K . Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med. 2009; 360(7):692-8. DOI: 10.1056/NEJMoa0802905. View

17.

Dalgleish A, Beverley P, Clapham P, Crawford D, Greaves M, Weiss R . The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 1984; 312(5996):763-7. DOI: 10.1038/312763a0. View

18.

Buchbinder S, Katz M, Hessol N, OMalley P, Holmberg S . Long-term HIV-1 infection without immunologic progression. AIDS. 1994; 8(8):1123-8. DOI: 10.1097/00002030-199408000-00014. View

19.

Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S . Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012; 367(5):411-22. PMC: 3687217. DOI: 10.1056/NEJMoa1202614. View

20.

Ho D, Neumann A, Perelson A, Chen W, Leonard J, Markowitz M . Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 1995; 373(6510):123-6. DOI: 10.1038/373123a0. View